Purchases and Sales Made in Q2 2022 in Neurocrine Biosciences Inc (NBIX)
This table provides information about the institutional ownership of Neurocrine Biosciences Inc (NBIX) during Q2 2022. The information is specifically focused on institutions that hold shares of NEUROCRINE BIOSCIENCES INC.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 15, 2022
Q2 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-57.5K- 91.46% |
$4.36M - $5.76M
|
5.37K
$640K
|
|
Aug 09, 2022
Q2 2022
|
Gw&K Investment Management, LLC
Boston, MA |
SELL
|
- |
-62.5K- 9.2% |
$4.74M - $6.26M
|
617K
$73.5M
|
|
Aug 12, 2022
Q2 2022
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-62.5K- 14.98% |
$4.74M - $6.26M
|
355K
$42.3M
|
|
Aug 12, 2022
Q2 2022
|
First Trust Advisors LP
Wheaton, IL |
SELL
|
- |
-68.7K- 10.73% |
$5.21M - $6.88M
|
572K
$68.1M
|
|
Aug 11, 2022
Q2 2022
|
Bank Of Montreal
Toronto, A6 |
SELL
|
- |
-71.8K- 86.83% |
$5.45M - $7.19M
|
10.9K
$1.3M
|
|
Aug 16, 2022
Q2 2022
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-83.9K- 63.71% |
$6.36M - $8.4M
|
47.8K
$5.7M
|
|
Aug 15, 2022
Q2 2022
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-84.4K- 86.65% |
$6.4M - $8.45M
|
13K
$1.55M
|
|
Jul 25, 2022
Q2 2022
|
Allspring Global Investments Holdings, LLC
|
SELL
|
- |
-90.4K- 44.58% |
$6.85M - $9.05M
|
112K
$13.4M
|
|
Nov 26, 2024
Q2 2022
|
Erste Asset Management Gmb H
Vienna, C4 |
SELL
|
- |
-97.1K- 80.31% |
$7.36M - $9.72M
|
23.8K
$2.83M
|
|
Aug 15, 2022
Q2 2022
|
Verition Fund Management LLC
Greenwich, CT |
SELL
|
- |
-99.7K- 96.34% |
$7.56M - $9.98M
|
3.79K
$451K
|
|
Aug 14, 2024
Q2 2022
|
Federation Des Caisses Desjardins Du Quebec
Levis, A8 |
SELL
|
- |
-109K- 99.12% |
$8.24M - $10.9M
|
970
$116K
|
|
Aug 15, 2022
Q2 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-137K- 27.48% |
$10.4M - $13.8M
|
363K
$43.2M
|
|
Aug 10, 2022
Q2 2022
|
Ubs Group Ag
|
SELL
|
- |
-141K- 62.8% |
$10.7M - $14.2M
|
83.8K
$9.98M
|
|
Aug 09, 2022
Q2 2022
|
Nordea Investment Management Ab
Stockholm, V7 |
SELL
|
- |
-143K- 27.44% |
$10.8M - $14.3M
|
378K
$45M
|
|
Aug 15, 2022
Q2 2022
|
Laurion Capital Management LP
New York, NY |
SELL
|
- |
-154KClosed |
$11.7M - $15.4M
|
0
$0
|
|
Aug 15, 2022
Q2 2022
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-155K- 18.63% |
$11.7M - $15.5M
|
677K
$80.6M
|
|
Aug 15, 2022
Q2 2022
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-164K- 26.07% |
$12.4M - $16.4M
|
465K
$55.4M
|
|
Aug 15, 2022
Q2 2022
|
Logos Global Management LP
San Francisco, CA |
SELL
|
- |
-175K- 36.84% |
$13.3M - $17.5M
|
300K
$35.7M
|
|
Aug 11, 2022
Q2 2022
|
Bellevue Group Ag
Kuesnacht, V8 |
SELL
|
- |
-179K- 5.93% |
$13.6M - $17.9M
|
2.84M
$339M
|
|
Aug 16, 2022
Q2 2022
|
International Biotechnology Trust PLC
London, X0 |
SELL
|
- |
-180K- 88.67% |
$13.6M - $18M
|
23K
$2.74M
|
|
Aug 15, 2022
Q2 2022
|
Man Group PLC
London, X0 |
SELL
|
- |
-219K- 88.5% |
$16.6M - $21.9M
|
28.4K
$3.39M
|
|
Aug 15, 2022
Q2 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-242K- 16.15% |
$18.3M - $24.2M
|
1.25M
$149M
|
|
Aug 15, 2022
Q2 2022
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-260KClosed |
$19.7M - $26M
|
0
$0
|
|
Aug 15, 2022
Q2 2022
|
Camber Capital Management LP
Boston, MA |
SELL
|
- |
-300KClosed |
$22.7M - $30M
|
0
$0
|
|
Aug 15, 2022
Q2 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-332K- 7.75% |
$25.2M - $33.3M
|
3.96M
$471M
|
|
Aug 15, 2022
Q2 2022
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-343K- 93.54% |
$26M - $34.3M
|
23.7K
$2.82M
|
|
Aug 15, 2022
Q2 2022
|
Baker Bros. Advisors LP
New York, NY |
SELL
|
- |
-677KClosed |
$51.3M - $67.7M
|
0
$0
|
|
Aug 15, 2022
Q2 2022
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-1.1M- 17.37% |
$83.1M - $110M
|
5.21M
$621M
|